Envision Healthcare — Debt Investor Presentation (October 2015)
35 slides from Envision Healthcare's debt investor presentation, Oct 28, 2015
Slide 1: Forward-Looking Statements
FORWARD-LOOKING STATEMENTS SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INFORMATION Forward-Looking Statements Certain statements and information in this presentation may be deemed to be "forward-looking statements" of Envision Healthcare Holdings, Inc. (“Envision”) within the meaning of th
Slide 2: Non-GAAP Financial Measures
NON-GAAP FINANCIAL MEASURES Presentation of Non-GAAP Measures This presentation includes statements regarding expected Adjusted EBITDA and Rural/Metro Pro Forma Adjusted EBITDA, which are not financial measures calculated and presented in accordance with generally accepted accounting principles in t
Slide 3: Non-GAAP Financial Measures
NON-GAAP FINANCIAL MEASURES Presentation of Non-GAAP Measures This presentation includes statements regarding expected Adjusted EBITDA and Rural/Metro Pro Forma Adjusted EBITDA, which are not financial ‘measures calculated and presented in accordance with generally accepted accounting principles in
Slide 4: Transaction overview
Transaction overview 5 Envision Healthcare Holdings, Inc. (“Envision” or the “Company”) (NYSE: EVHC) is a leading provider of physician-led, outsourced medical services in the U.S. with more than 35,000 employees and affiliated clinicians For the LTM period ended 9/30/2015, Envision generated net re
Slide 5: Sources and Uses / As Adjusted Capitalization
SOURCES AND USES / AS ADJUSTED CAPITALIZATION Sources and Uses As Adjusted Capitalization Note: Adjusted EBITDA and Rural/Metro Pro Forma Adjusted EBITDA as defined in Non-GAAP Financial Measures. Prior periods have been adjusted accordingly for comparability purposes. Rural/Metro Pro Forma Adjusted
Slide 6: Summary Terms
SUMMARY TERMS Borrower: Envision Healthcare Corporation (Borrower under the existing Term Loan) Facility: $750 million Term Loan B-2 Facility (the “Term Loan B”) Existing Incremental Facilities: $250 million, plus unlimited amounts provided Consolidated First Lien Net Leverage Ratio does not exceed
Slide 7: Transaction Timetable
October 2015 S M T W T F S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 TRANSACTION TIMETABLE Date Event October 28 Bank Meeting November 4 Commitments Due Week of November 9 Close and Fund Holiday Key Date November 2015 S M T W T F S 1 2 3 4 5 6 7 8 9 10 11 12
Slide 8: Transaction Timetable
TRANSACTION TIMETABLE October 2015 November 2015 Ss oM tT WT FS SMT WTF S 1203 12 3MBs 6 7 HE tiotiay Key Dato Date Event October 28 = Bank Meeting November 4 = Commitments Due Week of November 9 = Close and Fund == Envision 8 M@Mvear ARE
Slide 9: Investment Highlights
INVESTMENT HIGHLIGHTS 10 Leading Player in Large and Growing Outsourced Healthcare Services Markets Positioned at the Nexus of Rapidly Evolving Healthcare Landscape Differentiated, Integrated Service Model Across the Patient Continuum History of Strong Revenue and EBITDA Growth with Stable Cash Flow
Slide 10: Key Highlights
KEY HIGHLIGHTS Note: Adjusted EBITDA as defined in Non-GAAP Financial Measures. Prior periods have been adjusted accordingly for comparability purposes. See reconciliation in supplemental materials. $9.7M of insurance reserve adjustments for two significantly higher than expected malpractice cases f
Slide 11: Positioned at the Nexus of the Evolving Landscape
POSITIONED AT THE NEXUS OF THE EVOLVING LANDSCAPE 12 Healthcare reform driving new models of delivery and reimbursement Population health driving changes in managing care across the patient continuum Integrated care models improve outcomes, reduce cost Movement toward market centricity (space and sc
Slide 12: Leading Provider of Healthcare Services Across a Patient Continuum
A leading provider and manager of community-based medical transportation services A leading provider of integrated physician services to healthcare facilities A comprehensive provider of physician-led population health management solutions Over 50 Year History of Pioneering the Delivery of Care` LEA
Slide 13: Leading Outsourced Provider with National Scale and Strong Local Presence
LEADING OUTSOURCED PROVIDER WITH NATIONAL SCALE AND STRONG LOCAL PRESENCE AMR Operations – (38 States) EmCare Operations – (41 States) Evolution Health – (8 States) Top Market Centricity Opportunities Leading Market Position Provides Significant Competitive Advantages Benefits of Scale and Scope Rev
Slide 14: Multiple Levers to Drive Strong and Consistent Growth
Continued development of additional services that enhance the patient continuum Either de novo or through acquisitions MULTIPLE LEVERS TO DRIVE STRONG AND CONSISTENT GROWTH Same Store Organic Growth Net New Contracts Existing Services Integrated services / cross-selling Proven track record improving
Slide 15: EmCare: Leading Outsourced Provider of Integrated Facility-Based Physician Services
EMCARE: LEADING OUTSOURCED PROVIDER OF INTEGRATED FACILITY-BASED PHYSICIAN SERVICES 1. Management estimates of 2014 market size and EmCare outsourced market share. Integrated services offering Demonstrated track record of improving metrics High quality service drives patient and physician satisfacti
Slide 16: EmCare: Robust Growth Platform with Significant Momentum
EmCare Key Growth Drivers EMCARE: ROBUST GROWTH PLATFORM WITH SIGNIFICANT MOMENTUM Long-Term History of Highly Visible, Recurring Revenue with Recent Acceleration in Growth Organic Growth 13.0% 15.5% 17.3% 12.7% Organic EmCare Revenue Growth Breakdown1 Share Gains from Local and Regional Groups Expa
Slide 17: AMR: Leading Outsourced Provider of Community-Based Medical Transportation
Substantial scale advantages in ambulance services “AMR Medicine” drives best of class clinical outcomes and improved patient experience AMR Competitive Advantages AMR: LEADING OUTSOURCED PROVIDER OF COMMUNITY-BASED MEDICAL TRANSPORTATION SERVICES A Leader in Ambulance Market with Growing Positions
Slide 18: AMR: Business Realignment Accelerated Growth, Led to Margin Improvements
Positioned for Accelerated Revenue Growth AMR: BUSINESS REALIGNMENT ACCELERATED GROWTH, LED TO MARGIN IMPROVEMENTS Well-Positioned for Accelerated Revenue Growth and Continued Margin Improvements Increasing New Contract Win Rates Strengthened AMR Management Team Proven Superior Clinical Outcomes (AM
Slide 19: Evolution Health overview
Specializes in physician-led, population management services in the post-acute, home, mobile environment Focus on high risk, high cost and vulnerable populations with advanced illness and multiple chronic conditions Over 2,200 dedicated caregivers, and rapidly growing Leverages EmCare and AMR compet
Slide 20: Evolution Health: Integration Driven Growth with Demonstrated Market Traction
Strategic Deployment for Market Centricity EVOLUTION HEALTH: INTEGRATION DRIVEN GROWTH WITH DEMONSTRATED MARKET TRACTION Strategic Innovation with Strong Market Traction and Recent Acceleration in Growth Robust Clinical Care Model Risk Arrangements, Gain Sharing, Bundled Payments, Capitation Modular
Slide 21: 2015 Highlights
2015 HIGHLIGHTS 22 Envision’s 2015 Guidance: Adjusted EBITDA of $600M - $605M and Adjusted EPS of $1.28 - $1.30 8 to 9 percent implied Adjusted EBITDA growth includes lost Medicaid parity revenue at ~80% Adjusted EBITDA margin, offset by 2015 acquisitions EmCare acquisition of Emergency Medical Asso
Slide 22: 2015 Highlights
2015 HIGHLIGHTS 22 Envision's 2015 Guidance: > Adjusted EBITDA of $600M - $605M and Adjusted EPS of $1.28 - $1.30 — 8 to 9 percent implied Adjusted EBITDA growth includes lost Medicaid parity revenue at ~80% Adjusted EBITDA margin, offset by 2015 acquisitions EmCare acquisition of Emergency Medical
Slide 23: Envision to Acquire Rural/Metro
ENVISION TO ACQUIRE RURAL/METRO 24 Strategic Rationale Creates a leading outsourced healthcare transportation services company in the U.S. Combined company will offer superior services in: Emergency “911” Inter-facility Managed transportation services Non-government fire services (subscription) Comb
Slide 24: Rural/Metro: Established ambulance and fire services provider
Established ambulance and fire services provider 25 Net Revenue ($ in Millions) Adjusted EBITDA ($ in millions) Ambulance Services Segment Overview Leading provider of emergency and non-emergency ambulance services in the U.S. Nearly 100 exclusive contracts to provide 911 emergency services Thousand
Slide 25: Expanding on Our Regional Presence
Expanding on Our regional Presence 26 AMR Operations AMR / Rural/Metro Overlap Rural/Metro
Slide 26: Pro Forma Financials LTM 9/30/2015
Pro forma financials 27 LTM 9/30/2015 Revenue LTM 9/30/15 Pro Forma Adjusted EBITDA ($ in millions) Note: Adjusted EBITDA as defined in Non-GAAP Financial Measures. Prior periods have been adjusted accordingly for comparability purposes. Rural/Metro Pro Forma Adjusted EBITDA includes pro forma impac
Slide 27: Pro Forma Financials
PRO FORMA FINANCIALS (Sn mtions) M 9/30/2015 Revenue TM 9/30/15 Pro Forma Adjusted EBITD. | sss | $5,722 Envision Rural/Metro Total Envision Rural/Metro. ‘Synergies Total ew “Gunes ETOA notch po foma moat canter ager, src amenaners coer aduronerromeed axcegamorrare ad @ ® Envision 27 mootena hye mon
Slide 28: Strong Historical Revenue and EBITDA Growth
Net Revenue STRONG HISTORICAL REVENUE AND EBITDA GROWTH ’05-’14 CAGR: 10.4% ’05-’14 CAGR: 15.5% Note: $ in millions. Adjusted EBITDA as defined in Non-GAAP Financial Measures. Prior periods have been adjusted accordingly for comparability purposes. See reconciliation in supplemental materials. 2008
Slide 29: Continued Revenue and EBITDA Growth in 2015
CONTINUED REVENUE AND EBITDA GROWTH IN 2015 30 % Margin EmCare 12.5% 10.0% AMR 12.0% 12.9% Envision 12.3% 10.9% % Growth EmCare 29.1% AMR 10.4% Envision 22.4% Net Revenue Adjusted EBITDA Q3 2015 Financial Results Continued Strong Performance in 2015 Note: $ in millions. Adjusted EBITDA as defined in
Slide 30: Strong and Stable Cash Flows
STRONG AND STABLE CASH FLOWS 31 Note: DSO calculated based on last quarter of indicated period. Days Sales Outstanding Net CapEx as a % of Revenue Contract Retention Rate Top 10 Customers Tenure Recurring Revenue, Attractive Operating Margins and Relatively Low Capital Expenditure and Working Capita
Slide 31: Historical Ability to Reduce Leverage
HISTORICAL ABILITY TO REDUCE LEVERAGE 32 Note: $ in millions. Cash balance includes cash and all near cash items. Total Net Leverage-to-LTM Adjusted EBITDA Multiples Strong Cash Flow Supports De-Levering Key Events: IPO CD&R Acquisition Recap IPO Note Offering Acquisition Funding Pro Forma 3.2x 0.4x
Slide 32: Historical Ability to Reduce Leverage
HISTORICAL ABILITY TO REDUCE LEVERAGE Total Net Leverage: 'M Adjusted EBITDA Multiples 1 1 1 1 It 1 ' I 1 1 1 1 i 1 Il 1 1 1 I 1 i 1 I fl 1 1 1 I 1 1 ' 1 ' 1 ' 1 ' 1 1 1 2012 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ' 42x 1 1 1 1 1 2008 zo 22011 2011 03.2012 32013 sz 0M a8 2018 Key ‘oar Note ‘Acquistion Events:
Slide 33: Envision Adjusted EBITDA Reconciliation
ENVISION ADJUSTED EBITDA RECONCILIATION 1. 2005 related party management fees represent both Laidlaw and Onex management fees and 2013 includes $20M to terminate the CD&R consulting agreement Fiscal Year Ended December 31, ($ in millions) 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Net income
Slide 34: Rural/Metro Adjusted EBITDA Reconciliation
RURAL/METRO ADJUSTED EBITDA RECONCILIATION 1. Billing Restructuring Costs – Represents payroll related costs and temporary resources hired in excess of the stead state revenue cycle costs 2. Other – Represents non-recurring professional fees related to operational restructuring, IT projects for syst
Slide 35: Rural/Metro Pro Forma Adjusted EBITDA Reconciliation
RURAL/METRO PRO FORMA ADJUSTED EBITDA RECONCILIATION (ermtecs) tm 072015 Net Income (Loss) ($50.4) DOeprecation and amortzaton expense 330 Interest Expense 36 Income Tax Expense: G3) Discontinued Operations 00 Reported EBITDA si39 Iimpatrment of PPRE and Intangible assets 23 ‘Bing Restructuring Cost
Envision Healthcare Holdings — Debt Investor Presentation (October 2015) on 6ix